Cargando…

Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States

INTRODUCTION: Contemporary data describing treatment patterns, adverse events (AEs), and outcomes in patients with chronic lymphocytic leukemia (CLL) in clinical practice are lacking. We conducted a retrospective cohort study and assessed treatment patterns, AEs, health‐care resource use (HCRU), and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabadi, Shaum M., Goyal, Ravi K., Nagar, Saurabh P., Kaye, James A., Davis, Keith L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639180/ https://www.ncbi.nlm.nih.gov/pubmed/31144473 http://dx.doi.org/10.1002/cam4.2268

Ejemplares similares

Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population
por: Goyal, Ravi K., et al.
Publicado: (2021)

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis
por: Epperla, Narendranath, et al.
Publicado: (2020)

Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
por: Zhdanava, Maryia, et al.
Publicado: (2020)

Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
por: Lin, David, et al.
Publicado: (2021)

Cost of illness and economic burden of chronic lymphocytic leukemia
por: Blankart, Carl Rudolf, et al.
Publicado: (2013)

A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States
por: Zhang, Wenjie, et al.
Publicado: (2018)

Economic Burden of Anemia in an Insured Population
por: Nissenson, Allen R., et al.
Publicado: (2005)

Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
por: St. Peter, Wendy L., et al.
Publicado: (2018)

Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada
por: Lachaine, Jean, et al.
Publicado: (2021)

Real‐world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UK
por: Hillmen, Peter, et al.
Publicado: (2021)

Pericardial Involvement with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Rare Case of Constrictive Pericarditis
por: Ho, Natalie, et al.
Publicado: (2018)

Economic burden of paediatric-onset disabilities among young and middle-aged adults in the USA: a cohort study of privately insured beneficiaries
por: Whitney, Daniel, et al.
Publicado: (2019)

Joint Effects of Obesity and Vitamin D Insufficiency on Insulin Resistance and Type 2 Diabetes: Results from the NHANES 2001–2006
por: Kabadi, Shaum M., et al.
Publicado: (2012)

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes
por: Sherry, Barbara, et al.
Publicado: (2015)

The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States
por: Saxena, Kunal, et al.
Publicado: (2023)

Effect of marital status on survival in glioblastoma multiforme by demographics, education, economic factors, and insurance status
por: Xie, Jun‐Chao, et al.
Publicado: (2018)

Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
por: Shao, Jun, et al.
Publicado: (2020)

Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015–2019 in Guangdong, China
por: Zhan, Chunwang, et al.
Publicado: (2022)

Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States
por: Patel, Jeetvan G, et al.
Publicado: (2014)

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia
por: Guinn, Daphne, et al.
Publicado: (2017)

Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada
por: Lachaine, Jean, et al.
Publicado: (2023)

Financial burden imposed on the insured patients for private treatment: Evidence from a state of Iran
por: Etemadi, Manal, et al.
Publicado: (2019)

Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market
por: Shih, Ya-Chen Tina, et al.
Publicado: (2021)

New Proposal of Private Insurance Program for Dementia Patients: Design of Sustainable Private Insurance Program in Korea
por: Park, Kun-Woo, et al.
Publicado: (2017)

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
por: Zhou, Jing‐Dong, et al.
Publicado: (2016)

Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
por: Nan, Fang‐yu, et al.
Publicado: (2021)

Clinical and economic burden of adverse drug reactions
por: Sultana, Janet, et al.
Publicado: (2013)

Clinical and economic burden of procedural sedation-related adverse events and their outcomes: analysis from five countries
por: Saunders, Rhodri, et al.
Publicado: (2018)

Government regulation of private health insurance
por: Motaze, Nkengafac V, et al.
Publicado: (2015)

Private dental insurance expenditure in Brazil
por: Cascaes, Andreia Morales, et al.
Publicado: (2018)

Government regulation of private health insurance
por: Motaze, Nkengafac Villyen, et al.
Publicado: (2021)

The Impact of Health Insurance on Economic Burden for Hepatitis B Inpatients in China
por: ZHANG, Hua, et al.
Publicado: (2016)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Multivariate Path Analysis of Serum 25-Hydroxyvitamin D Concentration, Inflammation, and Risk of Type 2 Diabetes Mellitus
por: Kabadi, Shaum M., et al.
Publicado: (2013)

Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015
por: Koshiol, Jill, et al.
Publicado: (2022)

Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States
por: Yu, Tzy-Chyi, et al.
Publicado: (2019)

Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting
por: Chastek, Benjamin, et al.
Publicado: (2016)

The Economic Burden of Acute Myeloid Leukemia in Iran
por: Alipour, Vahid, et al.
Publicado: (2022)

Comparison of the mRNA expression profile of B‐cell receptor components in normal CD5‐high B‐lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70
por: Gladkikh, Aleena A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_41j5fqq5tib0sh4k1ih3p1pqhn